These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3044885)

  • 1. Reevaluation of urine C-peptide as measure of insulin secretion.
    Tillil H; Shapiro ET; Given BD; Rue P; Rubenstein AH; Galloway JA; Polonsky KS
    Diabetes; 1988 Sep; 37(9):1195-201. PubMed ID: 3044885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation of endogenous insulin secretion in association with treatment status: assessment by serum C-peptide and modified urinary C-peptide.
    Aoki Y
    Diabetes Res Clin Pract; 1991 Dec; 14(3):165-73. PubMed ID: 1778109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients.
    Sturis J; Polonsky KS; Shapiro ET; Blackman JD; O'Meara NM; van Cauter E
    Diabetologia; 1992 Jul; 35(7):681-9. PubMed ID: 1644248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide. Study in obese and diabetic subjects.
    Meistas MT; Rendell M; Margolis S; Kowarski AA
    Diabetes; 1982 May; 31(5 Pt 1):449-53. PubMed ID: 6759260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
    Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
    J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
    Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK
    Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
    Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
    Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
    Van Cauter E; Mestrez F; Sturis J; Polonsky KS
    Diabetes; 1992 Mar; 41(3):368-77. PubMed ID: 1551497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.
    Polonsky KS; Rubenstein AH
    Diabetes; 1984 May; 33(5):486-94. PubMed ID: 6373457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12.
    Byrne MM; Sturis J; Menzel S; Yamagata K; Fajans SS; Dronsfield MJ; Bain SC; Hattersley AT; Velho G; Froguel P; Bell GI; Polonsky KS
    Diabetes; 1996 Nov; 45(11):1503-10. PubMed ID: 8866553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.
    Bowman P; McDonald TJ; Shields BM; Knight BA; Hattersley AT
    Diabet Med; 2012 Jan; 29(1):90-3. PubMed ID: 21883437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide.
    Hoogwerf BJ; Barbosa JJ; Bantle JP; Laine D; Goetz FC
    Diabetes Care; 1983; 6(5):488-92. PubMed ID: 6400710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of urinary C-peptide to estimate insulin secretion during starvation.
    Brodows RG
    J Clin Endocrinol Metab; 1985 Oct; 61(4):654-7. PubMed ID: 3897259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
    Polonsky KS; Gumbiner B; Ostrega D; Griver K; Tager H; Henry RR
    Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous insulin secretion was suppressed during insulin therapy in NIDDM patients.
    Murayama Y; Kawai K; Nakamura S; Yamashita K
    Diabetes Res Clin Pract; 1990; 9(2):129-36. PubMed ID: 2198153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.